Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00473291 · ClinicalTrials.gov registry record
Vibration Response Imaging (VRI) in Management and Evaluation in Patients With Pleural Effusion
A clinical trial, sponsored by Deep Breeze.
- Completed
- Registry status
- 80
- Enrollment target
NCT00473291: Completed study, sponsored by Deep Breeze.
NCT00473291 is a clinical trial that has completed, run by Deep Breeze. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00473291 has completed, sponsored by Deep Breeze.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The primary purpose of this study is evaluate the VRI device's accuracy in diagnosis of pleural effusion (in comparison to chest x-ray and ultrasonography), and to assess the pleural effusion location and size. The VRI system uses pressure sensors (electronic stethoscopes) to record the energy created by the airflow in the lungs during breathing.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-12 |
What the finished NCT00473291 record still lists
NCT00473291 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00473291 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00473291 about?
NCT00473291 is a clinical study titled "Vibration Response Imaging (VRI) in Management and Evaluation in Patients With Pleural Effusion". The primary purpose of this study is evaluate the VRI device's accuracy in diagnosis of pleural effusion (in comparison to chest x-ray and ultrasonography), and to assess the pleural effusion location and size. The VRI system uses pressure sensors (electronic stethoscopes) to record the energy creat...
What is the current status of trial NCT00473291?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2006-11. Estimated completion is 2007-12.
Who is sponsoring clinical trial NCT00473291?
This trial is sponsored by Deep Breeze, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia